Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignancies.
Reed DR, Mascarenhas L, Manning K, Hale GA, Goldberg J, Gill J, Sandler E, Isakoff MS, Smith T, Caracciolo J, Lush RM, Juan TH, Lee JK, Neuger AM, Sullivan DM.
Reed DR, et al. Among authors: lee jk.
Cancer Med. 2016 Feb;5(2):294-303. doi: 10.1002/cam4.598. Epub 2015 Dec 29.
Cancer Med. 2016.
PMID: 26714427
Free PMC article.
Clinical Trial.